Published in:
01-10-2007 | Abstracts
Poster Presentations
Authors:
M. Tuccori, U. Moretti, F. Lapi, D. Coli, A. Testi, M. Moschini, A. Vannacci, C. Blandizzi, A. Mugelli, M. Del Tacca
Published in:
Drug Safety
|
Issue 10/2007
Login to get access
Excerpt
Background: Statins are widely prescribed hypolipidaemic drugs. Since lipids account for half of the dry matter of central nervous system (CNS) and are integral to myelin sheaths and synapses, recent interest was risen on potential psychiatric side effects of statins[1] including memory loss, depression, suicidality, aggression and antisocial behaviour. [2] …